Legal Representation
Attorney
Andrew N. Spivak
USPTO Deadlines
Next Deadline
1384 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-04-23)
Due Date
April 23, 2029
Grace Period Ends
October 23, 2029
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 23, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Jul 27, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jul 27, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 27, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Jul 27, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 27, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Oct 23, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Apr 23, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Mar 16, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Mar 15, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Feb 12, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Feb 12, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 22, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jan 22, 2019 | IUAF | S | USE AMENDMENT FILED |
| Jan 15, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 20, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 20, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 31, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 9, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 3, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 25, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jul 24, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 23, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of obesity and inducing weight loss
First Use Anywhere:
May 25, 2018
First Use in Commerce:
Oct 15, 2018
Additional Information
Design Mark
The mark consists of The stylized term "NALPROPION" with a capital "N". To the left of NALPROPION is a stylized logo comprised of two curved, triangular shapes strategically placed so as to form the outline of the letter "N". Underneath the term "NALPROPION" is the stylized word "PHARMACEUTICALS" in all capital letters.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"